With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...
Please provide your email address to receive an email when new articles are posted on . Perrigo announced that the FDA has approved mometasone furoate monohydrate, an intranasal corticosteroid nasal ...
The appointment marks McCann Hong Kong's first health care account. This is also the first time MSD has engaged an advertising agency to market this brand. The creative pitch, which took place in July ...
Credit: Getty Images. This is the first OTC formulation for Nasonex and is expected to be available later this year. The Food and Drug Administration (FDA) has approved the prescription to ...
DUBLIN, March 17, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the U.S.
With sales just shy of $1.3 billion in 2011, Nasonex allergy spray is Merck's fifth-best-selling drug. The rebuff comes at a tough time for the drugmaker, however. In August, it loses loses patent ...
June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback